✦ LIBER ✦

Abdominal Obesity and All-Cause and Cardiovascular Mortality in End-Stage Renal Disease

✍ Scribed by Maurizio Postorino; Carmen Marino; Giovanni Tripepi; Carmine Zoccali

Book ID: 119268058
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 436 KB
Volume: 53
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2008.12.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Arterial media calcification in end-stag

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality

✍ London, G. M. 📂 Article 📅 2003 🏛 Oxford University Press 🌐 English ⚖ 176 KB

Chlamydia pneumoniae, overall and cardio

Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD)

✍ Zoccali, Carmine; Mallamaci, Francesca; Tripepi, Giovanni; Parlongo, Saverio; Cu 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 71 KB

## Background: Cross-sectional and retrospective studies suggest that chlamydia pneumoniae infection may contribute importantly to the high cardiovascular risk of patients with end-stage renal disease (esrd). ## Methods: We investigated the relationship between c. pneumoniae serology and survival

Obesity, End-stage Renal Disease, and Su

Obesity, End-stage Renal Disease, and Survival in an Elderly Cohort With Cardiovascular Disease

✍ Janice P. Lea; Daryl O. Crenshaw; Stephen J. Onufrak; Britt B. Newsome; William 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Depression and Mortality in End-Stage Re

Depression and Mortality in End-Stage Renal Disease

✍ Nisha Ver Halen; Daniel Cukor; Melissa Constantiner; Paul L. Kimmel 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 182 KB

Reduced LV-EF at Inducting of Hemodialys

Reduced LV-EF at Inducting of Hemodialysis Therapy Stratify The Risk of Cardiovascular and All-cause Mortality in End-Stage Renal Disease Patients

✍ Toru Aoyama; Miho Tanaka; Daisuke Kamoi; Yoshihiro Kawamura; Kazuhiro Kawashima; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Antibody to oxidized low-density lipopro

Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease

✍ Shoji, Tetsuo; Fukumoto, Mariko; Kimoto, Eiji; Shinohara, Kayo; Emoto, Masanori; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

## Background: Immune response to oxidized low-density lipoprotein (oxldl) may modulate the process of atherogenesis and cardiovascular disease. ## Methods: We performed a prospective, observational cohort study in 249 patients with end-stage renal disease (esrd) to examine whether the serum tite